Further, ChIP-seq analysis has revealed that a number of binding sites of NCOA3 are associated with genes with a predictive value for breast cancer patient outcome56, supporting an important role of this co-regulator in tamoxifen response. Here, NCOA3 is linked to breast carcinoma.